VANCOUVER, BC, Jan. 6, 2026 /PRNewswire/ - GoldMining Inc. (the "Company" or "GoldMining") (TSX: GOLD) (NYSE American: GLDG) is pleased to report additional assay results from the 2025 RC ...
Exvade Biosciencetm, a clinical-stage neuro-oncology company advancing a breakthrough platform for treating aggressive brain cancers, today highlighted ongoing enrollment in a Phase 1 clinical trial ...
Simple finger-prick blood samples that can be collected at home and mailed to laboratories without refrigeration or prior ...
Introduction After the WHO prequalified the first vaccine against mpox, we aimed to identify the influence of vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results